These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats. Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819 [TBL] [Abstract][Full Text] [Related]
25. Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Tomlinson DR; Robinson JP; Compton AM; Keen P Diabetologia; 1989 Sep; 32(9):655-9. PubMed ID: 2477293 [TBL] [Abstract][Full Text] [Related]
26. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'. Willars GB; Calcutt NA; Tomlinson DR Diabetologia; 1987 Apr; 30(4):239-43. PubMed ID: 2439402 [TBL] [Abstract][Full Text] [Related]
27. Proteins of slow axonal transport in sciatic motoneurones of rats with streptozotocin-induced diabetes or galactosaemia. Tomlinson DR; Filliatreau G; Figliomeni B; Hassig R; Di Giamberardino L; Willars GB Diabetes Res Clin Pract; 1990 Apr; 9(1):15-21. PubMed ID: 1693556 [TBL] [Abstract][Full Text] [Related]
28. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil. Tomlinson DR; Moriarty RJ; Mayer JH Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576 [TBL] [Abstract][Full Text] [Related]
29. Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetes. McLean WG; Pekiner C; Cullum NA; Casson IF Mol Neurobiol; 1992; 6(2-3):225-37. PubMed ID: 1476675 [TBL] [Abstract][Full Text] [Related]
30. Altered GAP-43 immunoreactivity in regenerating sciatic nerve of diabetic rats. Pekiner C; Dent EW; Roberts RE; Meiri KF; McLean WG Diabetes; 1996 Feb; 45(2):199-204. PubMed ID: 8549865 [TBL] [Abstract][Full Text] [Related]
31. Nerve conduction and antioxidant levels in experimentally diabetic rats: effects of streptozotocin dose and diabetes duration. Van Dam PS; Van Asbeck BS; Bravenboer B; Van Oirschot JF; Marx JJ; Gispen WH Metabolism; 1999 Apr; 48(4):442-7. PubMed ID: 10206435 [TBL] [Abstract][Full Text] [Related]
32. Effect of 4-methylcatechol on sciatic nerve growth factor level and motor nerve conduction velocity in experimental diabetic neuropathic process in rats. Hanaoka Y; Ohi T; Furukawa S; Furukawa Y; Hayashi K; Matsukura S Exp Neurol; 1992 Feb; 115(2):292-6. PubMed ID: 1735473 [TBL] [Abstract][Full Text] [Related]
33. Treadmill training modifies KIF5B motor protein in the STZ-induced diabetic rat spinal cord and sciatic nerve. Rahmati M; Gharakhanlou R; Movahedin M; Mowla SJ; Khazani A; Fouladvand M; Jahani Golbar S Arch Iran Med; 2015 Feb; 18(2):94-101. PubMed ID: 25644797 [TBL] [Abstract][Full Text] [Related]
34. A comparison of the effects of acrylamide and experimental diabetes on the retrograde axonal transport of proteins in the rat sciatic nerve: analysis by two-dimensional polyacrylamide gel electrophoresis. Logan MJ; McLean WG J Neurochem; 1988 Jan; 50(1):183-9. PubMed ID: 2447233 [TBL] [Abstract][Full Text] [Related]
35. Motor nerve conduction velocity and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes. Whiteley SJ; Tomlinson DR Exp Neurol; 1985 Aug; 89(2):314-21. PubMed ID: 3160601 [TBL] [Abstract][Full Text] [Related]
36. Impaired induction of vasoactive intestinal polypeptide after sciatic nerve injury in the streptozotocin-diabetic rat. Calcutt NA; Mizisin AP; Yaksh TL J Neurol Sci; 1993 Nov; 119(2):154-61. PubMed ID: 8277329 [TBL] [Abstract][Full Text] [Related]
37. Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Fernyhough P; Diemel LT; Tomlinson DR Diabetologia; 1998 Mar; 41(3):300-6. PubMed ID: 9541170 [TBL] [Abstract][Full Text] [Related]
38. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits. Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114 [TBL] [Abstract][Full Text] [Related]
39. Reduction of cyclic AMP in the sciatic nerve of rats made diabetic with streptozotocin and the mechanism involved. Shindo H; Tawata M; Onaya T J Endocrinol; 1993 Mar; 136(3):431-8. PubMed ID: 7682591 [TBL] [Abstract][Full Text] [Related]
40. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition. Willars GB; Calcutt NA; Compton AM; Tomlinson DR; Keen P J Neurol Sci; 1989 Jun; 91(1-2):153-64. PubMed ID: 2473171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]